BCR/ABL1 fluorescence in situ hybridization fusion signals on both copies of chromosome 22 in a philadelphia-masked chronic myeloid leukemia case: Implication for the therapy

3Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The cytogenetic hallmark of Chronic Myeloid Leukemia (CML) is the presence of Philadelphia (Ph) chromosome, which results from a reciprocal translocation t(9;22)(q34;q11). In this report, we describe a CML patient with no evidence of Ph chromosome but trisomy of chromosome 8 as single cytogenetic abnormality and a typical e14a2 (b3a2) BCR-ABL1 fusion transcript. Fluorescence In Situ Hybridization (FISH) analysis revealed an uncommon signal pattern: the fusion signals were located on both copies of chromosome 22. During the course of the disease the appearance of the p.(Tyr315Ile) mutation was recorded. To the best of our knowledge this is the first Ph chromosome-negative CML case with e14a2 (b3a2) BCR-ABL1 transcript and p.(Tyr315Ile) mutation.

Cite

CITATION STYLE

APA

Soriani, S., Guido, V., Bertani, G., Cesana, C., Motta, V., De Canal, G., … Romitti, L. (2021). BCR/ABL1 fluorescence in situ hybridization fusion signals on both copies of chromosome 22 in a philadelphia-masked chronic myeloid leukemia case: Implication for the therapy. Hematology Reports, 13(1). https://doi.org/10.4081/hr.2021.8795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free